Paysign, Inc. · NASDAQ:PAYS
Paysign — Investor Presentation (November 2020)
19 slides from Paysign's investor presentation, November 2020

Slide 1: Investor Presentation
1 Investor Presentation NASDAQ: PAYS • November 2020 ©2020 Paysign, Inc. All rights reserved. Paysign® is a registered trademark.

Slide 2: Important Notices
2 Important Notices Forward-Looking Statements and Use of Non-GAAP Financial Information This presentation may include "forward-looking statements." To the extent that the information presented in this presentation discusses financial projections, information, or expectations about Paysign, Inc.’s (

Slide 3: Presentation Overview
33 Presentation Overview • Company Overview • Investment Highlights • Company Milestones • Growth Strategy and Markets • Technology Platform • Competitive Advantages • Business Drivers • Investments by the Numbers • Financial Highlights • Leadership and Directors

Slide 4: Paysign: A Reliable Payments Partner
4 Paysign ® A Reliable Payments Partner Paysign provides innovative payment products designed to reward consumers, clients, and employees, delivers patient affordability solutions to the pharmaceutical industry, and offers a mobile-first digital banking solution to businesses and their consumers. Pa

Slide 5: Company Overview
5 Company Overview Financial Snapshot • Paysign was incorporated in 2001 and is headquartered in Stock Price (11/27/20) $5.02 Henderson, Nevada. 52 Week Range $3.63 – $10.98 • We are an experienced and trusted provider of prepaid debit card payment solutions and integrated payment processing Market

Slide 6: Investment Highlights
6 Investment Highlights Revenue Growth Products and Solution Leadership Fast-growing, high-margin, Large market opportunity in corporate Highly accomplished and profitable business with incentives, consumer incentives, and digital experienced management predictable recurring revenues bank account wi

Slide 7: Company Milestones
7 Company Milestones 2018 May – Formation of experienced Board of Directors. 2006 2011 2020 Aug – The company is listed Company begins The company’s on NASDAQ, has more than The company launches operating as 3PEA first plasma 2.2M cardholders and $621M the Patient Affordability International, Inc. c

Slide 8: Growth Strategy
8 Growth Strategy Driving Profitable Growth Grow Diversify Build Deliver Protect and grow core New products: New payment capabilities Deliver operational excellence plasma business Paysign Premier and product features Paysign Rewards Make data-driven decisions Partner with pharma Acquire new with co

Slide 9: 2023 U.S. Open-Loop Prepaid Market Forecast
9 2023 U.S. Open-Loop Prepaid Market Forecast Total Prepaid Market Market Segments Paysign Where We Operate Products $1.72B (0.4%) $93.8B (23.3%) Paysign Premier Digital Bank Account Campus Financial Services (GPR) $84.3B (20.9%) CAGR -2%, 2018-2023 Government Benefits (Social Security, TANF, State

Slide 10: Providing Donor Compensation Solutions Since 2011
10 Providing Donor Compensation Solutions Since 2011 Paysign Processed Over 17M Donor Compensation Payments in 2019 US Plasma Centers U.S. Plasma Collections by Year2 60 Millions 53.5M 50 48.7M 855 42.4M 40 38.3M 35.5M 32.6M Total U.S. Plasma 30 Center Locations1 Paysign Share 35% 20 17.7M 15.1M 10.

Slide 11: Patient Affordability Solutions
11 Patient Affordability Solutions Helping Patients Offset Their Out-of-Pocket Rx Costs Paysign’s Patient Affordability Solutions help pharmaceutical 19% brands deploy coupon programs that are used by commercially Percent of commercially insured insured patients to offset their out-of-pocket (OOP) c

Slide 12: A Full-Service Provider
12 A Full-Service Provider Cardholder Self-Service Client API-Based 24/7/365 Fraud and Portals and Partner Portal Solutions In-House, Bilingual Chargeback Mobile Apps Customer Care Management Program Management Services Full-service, end-to-end, card-based solutions as both a processor and program m

Slide 13: Competitive Advantages
13 Competitive Advantages The Competition End-to-End Solutions: Paysign is both the processor and Limited account management services. Clients are asked program manager to choose between a processor or a program manager Direct Connection: Paysign connects directly to the Fed for More downtime due to

Slide 14: Business Drivers
14 Business Drivers Cumulative $6 Funds Loaded $1,200 Millions Millions 5.3 Cards Issued $5 on Cards $1,000 $973.2 4.4 $882M $882.3 5.3M $4 $800 3.5 $620.8 $3 $600 2.5 2019 Total Funds $408.3 $2 1.6 Loaded on Cards $400 $288.5 45% $1 $200 $0 CAGR 2016-2019 $0 2016 2017 2018 2019 SEP 2020 2016 2017 2

Slide 15: Investment by the Numbers
15 Investment by the Numbers 2020 TTM SEP 2020 2020 TTM Revenue Adjusted EBITDA Debt Total Assets $26.6M ($1.0M) $0 $71.1M Revenue by Industry Total Revenue Growth & $26.6M Pharma, $1,240,665 TTM 2020 $24,733,046 Other, $658,261 Diversification $34.7M 45% 2019 $26,994,929 $7,372,990 Other, $298,734

Slide 16: Financial Highlights
16 Financial Highlights Income Statement Summary Revenue and Reconciliation of Net Income to Adjusted EBITDA

Slide 17: Leadership Team
1177 Leadership Team Dan Spence Mark Attinger Joan Herman Co-Founder, Director, Chief Financial Officer Chief Operating Officer and EVP Attinger joined Paysign in 2018, and Director Dan Spence has been a driving bringing 30 years of leadership, Herman joined Paysign in 2017, force at Paysign since 2

Slide 18: Independent Directors
18 Independent Directors • Current CEO and president of Green Dot Corporation (NYSE: GDOT), current market cap $2.7B Dan Henry • Former CEO of NetSpend (2008-2013); grew annual revenue from $129M to $351M, with over 2.4M Chairman of the Board, cardholder accounts; NetSpend acquired by Total System S

Slide 19: Thank you!
19 Thank you! 2615 St Rose Parkway Jim McCroy Office: 702.453.2221 Henderson, NV 89052 Investor Relations Fax: 702.453.2223 United States ir@paysign.com Direct: 702.749.7269 ©2020 Paysign, Inc. All rights reserved.
Source: Internet Archive copy of paysign.com
More decks from Paysign, Inc.
Q2 2026 Earnings Presentation21 slides · Aug 5, 2026
Investor Presentation (August 2026)21 slides · August 2026
East Coast IDEAS Conference 202621 slides · Jun 11, 2026
Oppenheimer 11th Annual Emerging Growth Conference (February 2026)23 slides · Feb 3, 2026
17th Annual Southwest IDEAS Investor Conference 202523 slides · Nov 20, 2025
Lake Street Best Ideas Growth BIG9 Conference 202523 slides · Sep 11, 2025